Despite high awareness, ICH E6(R3) adoption is stalling, only 19% of organizations report significant change.
Why Early Alignment on Risk Tolerance Is Critical for Clinical Trials
Early alignment on risk tolerance is essential to ensure efficient, compliant trial execution.
TRI Fest: Where Remote Becomes Remarkable
TRI Fest 2025 brought our team together for a day of collaboration and a bit of friendly chaos.
World Patient Safety Day 2025
This World Patient Safety Day, we’re shining a light on how healthcare professionals can build safety into every interaction.
ICH E6 (R3) and Risk-Based Quality Management
This webinar unpacked the major shifts in ICH E6 (R3), showing how teams can embrace RBQM.
ICH E6 (R3) Is Here, But Only 19% Are Ready
ICH E6 (R3) is here, but only 19% of the industry is ready. While awareness is high, meaningful action is lagging.
Powering a Risk-Based Approach to Clinical Trials
TRI is proud to join the Veeva R&D Summit as a Product Partner, showcasing our collaboration.
Appointment Announcement – Jamie Moss, Executive Chair
We’re excited to announce the appointment of Jamie Moss, new Executive Chair.
The Quality Issue – August 2025
Join our ICH E6(R3) live panel webinar, explore ACRO highlights, and connect with TRI this autumn.
5 Mistakes That Could Compromise Your Clinical Trial
Explore five common mistakes that can derail your clinical trial and how OPRA helps teams manage risk.